Camden National Corporation (NASDAQ:CAC) Files An 8-K Regulation FD Disclosure
Item 7.01
|
Regulation FD Disclosure.
|
presentation with information about the Company for an investor
conference to be held on May15-17, 2017. The investor
presentation is attached as Exhibit 99.1. The investor
presentation is being furnished to Item 7.01, and the information
contained therein shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, or otherwise
subject to the liabilities under that Section. Furthermore, the
information contained in Exhibit 99.1 shall not be deemed to be
incorporated by reference into the filings of the Company under
the Securities Act of 1933.
|
Item 9.01
|
Financial Statements and Exhibits.
|
|
Exhibit No.
|
Description
|
|
99.1
|
Electronic investor presentation slides.
|
About Camden National Corporation (NASDAQ:CAC)
Camden National Corporation is a bank holding company. The Company is a diversified financial services provider. The primary business of the Company and its subsidiaries is to attract deposits from, and to extend loans to, consumer, institutional, municipal, non-profit and commercial customers. The Company offers commercial and consumer banking products and services through its subsidiary, Camden National Bank (the Bank), and brokerage and insurance services through Camden Financial Consultants (Camden Financial), a division of the Bank. The Company also offers investment management and fiduciary services through its subsidiary, Acadia Trust, N.A. (Acadia Trust), a federally-regulated, non-depository trust company headquartered in Portland, Maine. The Bank’s subsidiary, Healthcare Professional Funding Corporation (HPFC), provides specialized lending to dentists, optometrists and veterinarians across the United States. Camden National Corporation (NASDAQ:CAC) Recent Trading Information
Camden National Corporation (NASDAQ:CAC) closed its last trading session 00.00 at 41.48 with 46,321 shares trading hands.
